Access the UK market with confidence
Entering the UK market requires more than just registration—it requires the right regulatory ...
Recent clarification in Sweden’s clinical trial legislation
From 1 July 2026, a clarification in the Swedish Medicines Act has further defined the role of ...
Improved flexibility for CTIS submissions
A new “Article 11 workaround” is addressing a long-standing limitation in CTIS when working with ...
When your team needs reinforcement, not recruitment
Not every challenge calls for a permanent hire. Sometimes an experienced specialist is all it takes ...
Delivering outcomes that move projects forward
Our focus is on delivering the results you need—so your projects can keep moving forward. We've ...
Medtech Compliance Forum by Aurevia & RAPS - part of Labquality Days: 11-12 February 2027
Aurevia is pleased to announce a new partnership with RAPS, the Regulatory Affairs Professionals ...
Managing the post-summer workload
Autumn often brings a full pipeline of activities, tight timelines, and competing priorities. For ...
Aurevia Poland joins POLCRO
We're proud to share that Aurevia Poland has been admitted to POLCRO, the Polish Association of ...
Expanding into the EU market as a medical device or IVD manufacturer?
Expanding into the EU market as a medical device or IVD manufacturer? For non-EU/EEA companies, ...